Subthreshold grid laser versus intravitreal bevacizumab as second-line therapy for macular edema in branch retinal vein occlusion recurring after conventional grid laser treatment
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Subthreshold grid laser versus intravitreal bevacizumab as second-line therapy for macular edema in branch retinal vein occlusion recurring after conventional grid laser treatment'. Together they form a unique fingerprint.